Completed PHASE2 INTERVENTIONAL 2-arm NCT01636570

Vitamin D3 Supplementation for Heart Failure Patients

Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients

Sponsor: Heidi Moretti, MS, RD

Conditions Cardiomyopathy Congestive Heart Failure Heart Failure Vitamin D Deficiency

Interventions Placebo Comparator: Sugar Pill Vitamin D3 (cholecalciferol)

Updated 6 times since 2017 Last updated: Apr 24, 2017 Started: Aug 31, 2012 Primary completion: Apr 30, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cardiomyopathy and Congestive Heart Failure, this trial is completed. The trial is conducted by Heidi Moretti, MS, RD and has accumulated 6 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heidi Moretti, MS, RD
Saint Patrick Hospital

Data source: Saint Patrick Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Missoula, United States